Basta Steven L
Insider CIK 1417397 · CBYL Director · MNLO See Remarks, Director · PHAT President and CEO, Director · VIVE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PHAT Phathom Pharmaceuticals, I | F Tax w/h | 2026-02-10 | 2026-02-12 | 6,277 | $12.82 | $80.5K | 373,315 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2026-02-10 | 2026-02-12 | 12,362 | — | $0 | 379,592 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2026-01-02 | 2026-01-02 | 226,156 | — | $0 | 221,156 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2026-01-02 | 2026-01-02 | 251,034 | — | $0 | 364,820 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2025-12-17 | 2025-12-19 | 62,038 | — | $0 | 145,288 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | F Tax w/h | 2025-12-17 | 2025-12-19 | 31,502 | $15.36 | $483.9K | 113,786 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2025-12-12 | 2025-12-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | M Exercise deriv | 2025-11-28 | 2025-12-02 | 90,000 | — | $0 | 180,000 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | M Exercise | 2025-11-28 | 2025-12-02 | 90,000 | — | $0 | 131,625 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | F Tax w/h | 2025-11-28 | 2025-12-02 | 48,375 | $15.62 | $755.6K | 83,250 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | M Exercise deriv | 2025-09-25 | 2025-09-26 | 90,000 | — | $0 | 270,000 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | F Tax w/h | 2025-09-25 | 2025-09-26 | 48,375 | $11.66 | $564.1K | 41,625 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | M Exercise | 2025-09-25 | 2025-09-26 | 90,000 | — | $0 | 90,000 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2025-04-03 | 2025-04-03 | 1,085,000 | — | $0 | 1,085,000 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2025-04-03 | 2025-04-03 | 360,000 | — | $0 | 360,000 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2024-12-12 | 2024-12-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2024-01-01 | 2024-01-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2023-12-13 | 2023-12-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award deriv | 2023-01-03 | 2023-01-05 | 72,000 | — | $0 | 72,000 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2022-08-10 | 2022-08-12 | 20,500 | — | $0 | 20,500 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award deriv | 2022-01-04 | 2022-01-06 | 48,000 | — | $0 | 48,000 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | D To issuer | 2021-12-15 | 2021-12-17 | 28 | $1.41 | $39 | 25 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2021-07-19 | 2021-07-20 | 20,500 | — | $0 | 20,500 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award deriv | 2021-06-23 | 2021-06-25 | 116,200 | — | $0 | 116,200 | SEC↗ |
| VIVE | A Award deriv | 2021-01-20 | 2021-01-22 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award deriv | 2020-09-21 | 2020-09-22 | 165,000 | — | $0 | 165,000 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-08-03 | 2020-08-05 | 22,500 | — | $0 | 22,500 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-04-03 | 2020-04-07 | 14,499 | — | $0 | 536,537 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-19 | 2020-03-23 | 45,000 | — | $0 | 45,000 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-03-09 | 2020-03-11 | 7,108 | — | $0 | 522,038 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | M Exercise deriv | 2019-12-11 | 2019-12-13 | 14,000 | $1.83 | $25.6K | 357,641 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | M Exercise deriv | 2019-12-11 | 2019-12-13 | 238,800 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | M Exercise deriv | 2019-12-11 | 2019-12-16 | 238,800 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | M Exercise deriv | 2019-12-11 | 2019-12-16 | 14,000 | $1.83 | $25.6K | 357,641 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | M Exercise | 2019-12-11 | 2019-12-13 | 14,000 | $1.83 | $25.6K | 509,764 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | M Exercise | 2019-12-11 | 2019-12-13 | 238,800 | — | $0 | 580,974 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | F Tax w/h | 2019-12-11 | 2019-12-13 | 85,210 | $4.52 | $385.1K | 495,764 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | F Tax w/h | 2019-12-11 | 2019-12-16 | 85,210 | $4.52 | $385.1K | 495,764 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | M Exercise | 2019-12-11 | 2019-12-16 | 238,800 | — | $0 | 580,974 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | M Exercise | 2019-12-11 | 2019-12-16 | 14,000 | $1.83 | $25.6K | 509,764 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award deriv | 2019-11-26 | 2019-11-27 | 660,000 | — | $0 | 660,000 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2019-07-29 | 2019-07-31 | 238,800 | — | $0 | 1,050,100 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2019-07-29 | 2019-08-07 | 238,800 | — | $0 | 1,050,100 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award deriv | 2019-05-29 | 2019-05-31 | 35,000 | — | $0 | 35,000 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award | 2019-04-01 | 2019-04-03 | 24,199 | — | $0 | 24,199 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award deriv | 2019-01-15 | 2019-01-16 | 35,000 | — | $0 | 35,000 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2018-12-10 | 2018-12-12 | 141,900 | — | $0 | 141,900 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award deriv | 2018-09-13 | 2018-09-14 | 70,000 | — | $0 | 70,000 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2018-05-03 | 2018-05-04 | 212,850 | — | $0 | 669,400 | SEC↗ |
| CBYL KalVista Pharmaceuticals, | M Exercise deriv | 2016-11-21 | 2016-11-22 | 1,125 | — | $0 | 0 | SEC↗ |
| CBYL KalVista Pharmaceuticals, | F Tax w/h | 2016-11-21 | 2016-11-22 | 1,026 | $8.59 | $8.8K | 99 | SEC↗ |
| CBYL KalVista Pharmaceuticals, | U Tender | 2016-11-21 | 2016-11-22 | 99 | $8.59 | $850 | 0 | SEC↗ |
| CBYL KalVista Pharmaceuticals, | M Exercise | 2016-11-21 | 2016-11-22 | 1,125 | $7.84 | $8.8K | 1,125 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | A Award deriv | 2015-08-03 | 2015-08-05 | 15,750 | — | $0 | 15,750 | SEC↗ |